Found: 37
Select item for more details and to access through your institution.
Chemotherapy-induced changes in tumor consistency can allow gross total resection of previously unresectable brainstem pilocytic astrocytoma.
- Published in:
- Journal of Clinical Imaging Science, 2021, v. 11, p. 1, doi. 10.25259/SNI_594_2020
- By:
- Publication type:
- Article
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 1, p. 105, doi. 10.1007/s11060-024-04706-2
- By:
- Publication type:
- Article
Early imaging marker of progressing glioblastoma: a window of opportunity.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 629, doi. 10.1007/s11060-020-03565-x
- By:
- Publication type:
- Article
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 1, p. 97, doi. 10.1007/s11060-019-03271-3
- By:
- Publication type:
- Article
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 1, p. 127, doi. 10.1007/s11060-015-2020-x
- By:
- Publication type:
- Article
A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 1, p. 191, doi. 10.1007/s11060-015-1894-y
- By:
- Publication type:
- Article
Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 120, n. 2, p. 431, doi. 10.1007/s11060-014-1571-6
- By:
- Publication type:
- Article
cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 115, n. 2, p. 249, doi. 10.1007/s11060-013-1221-4
- By:
- Publication type:
- Article
A risk model for prediction of 30-day readmission rates after surgical treatment for colon cancer.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 8, p. 1529, doi. 10.1007/s00384-020-03605-y
- By:
- Publication type:
- Article
A glioblastoma neurosphere line with alternative lengthening of telomeres.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.
- Published in:
- Current Oncology, 2021, v. 28, n. 2, p. 1537, doi. 10.3390/curroncol28020145
- By:
- Publication type:
- Article
Prevalence and Inpatient Hospital Outcomes of Malignancy-Related Ascites in the United States.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2021, v. 38, n. 1, p. 47, doi. 10.1177/1049909120928980
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 834, doi. 10.1634/theoncologist.2016-0287
- By:
- Publication type:
- Article
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.
- Published in:
- 2019
- By:
- Publication type:
- case study
Chemotherapy-induced changes in tumor consistency can allow gross total resection of previously unresectable brainstem pilocytic astrocytoma.
- Published in:
- Surgical Neurology International, 2021, v. 12, p. 1, doi. 10.25259/SNI_594_2020
- By:
- Publication type:
- Article
Relationship between insurance status and interhospital transfers among cancer patients in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac143
- By:
- Publication type:
- Article
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac012
- By:
- Publication type:
- Article
Hospitalization rates for complications due to systemic therapy in the United States.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86911-x
- By:
- Publication type:
- Article
Molecular and Morphologic Correlates of the Alternative Lengthening of Telomeres Phenotype in High-Grade Astrocytomas.
- Published in:
- Brain Pathology, 2013, v. 23, n. 3, p. 237, doi. 10.1111/j.1750-3639.2012.00630.x
- By:
- Publication type:
- Article
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1342, doi. 10.3390/cancers15041342
- By:
- Publication type:
- Article
Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2946, doi. 10.3390/cancers14122946
- By:
- Publication type:
- Article
Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08507-3
- By:
- Publication type:
- Article
Factors associated with unplanned readmissions and costs following resection of brain metastases in the United States.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01641-4
- By:
- Publication type:
- Article
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report.
- Published in:
- Journal of Neurosurgery, 2019, v. 23, n. 6, p. 719, doi. 10.3171/2019.2.PEDS18480
- By:
- Publication type:
- Article
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1–Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 10, p. 1112, doi. 10.1001/jamadermatol.2023.2621
- By:
- Publication type:
- Article
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S155, doi. 10.1093/neuonc/noae001
- By:
- Publication type:
- Article
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S165, doi. 10.1093/neuonc/noae021
- By:
- Publication type:
- Article
Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S89, doi. 10.1093/neuonc/noad245
- By:
- Publication type:
- Article
Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. S16, doi. 10.1093/neuonc/noac130
- By:
- Publication type:
- Article
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1845, doi. 10.1093/neuonc/noab172
- By:
- Publication type:
- Article
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 1, p. 94, doi. 10.1093/neuonc/noz164
- By:
- Publication type:
- Article
ACTR-33. TUMOR TISSUE PENETRATION AND PHARMACODYNAMICS OF ONC201 IN ADULT RECURRENT GLIOBLASTOMA PATIENTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi18, doi. 10.1093/neuonc/noy148.066
- By:
- Publication type:
- Article
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 10, p. 1143, doi. 10.1093/neuonc/nor091
- By:
- Publication type:
- Article